All terms in DRUGBANK

Label Id Description
1,4-dithio-beta-D-glucopyranose DB03857
Pentane-1,5-Diamine DB03854 [A foul-smelling diamine formed by bacterial decarboxylation of lysine. [PubChem]]
2-aminooxyethyl-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl]-methyl-sulfonium DB02523
L-Threonohydroxamate 4-Phosphate DB03855
2',3'-O-{4-[Hydroxy(oxido)-λ5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate) DB02524
Eucalyptol DB03852 [Eucalyptol is naturally produced cyclic ether and monoterpenoid. Eucalyptol is an ingredient in many brands of mouthwash and cough suppressant. It controls airway mucus hypersecretion and asthma via anti-inflammatory cytokine inhibition. Eucalyptol is an effective treatment for nonpurulent rhinosinusitis. Eucalyptol reduces inflammation and pain when applied topically. It kills leukaemia cells in vitro.]
Flaviolin DB02521
Reactive Red 6 hapten DB03853
Phosphonopyruvate DB02522
Jaspisamide A DB03850
Carbazole Butanoic Acid DB03851
Ditiocarb DB02520 [A chelating agent that has been used to mobilize toxic metals from the tissues of man and experimental animals. It is the main metabolite of DISULFIRAM.]
PD150606 DB02570
2-Amino-6-Oxo-Hexanoic Acid DB02571
Epoprostenol DB01240 [A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from prostaglandin endoperoxides in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension.]
Flosequinan DB13228 [Flosequinan was approved in the USA and the UK for a year prior to being withdrawn from the market due to increased mortality in chronic heart failure patients, found in drug trials [A174979].]
Influenza B virus B/Maryland/15/2016 BX-69A antigen (formaldehyde inactivated) DB14559 [A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". This defence includes the production of humoral immunity through the development of antibodies (through memory B cells) and of cell-mediated immunity through the production of T-lymphocytes. Upon re-exposure to infectious influenza virus, the immune system is prepared to identify and destroy the virus as there are circulating antibodies that recognize that particular component of the virus that it was previously exposed to. There are two basic types of vaccines available: inactivated influenza vaccine (IIV) and live attenuated influenza vaccine (LAIV). Inactivated vaccines contain a virus particle that has been grown in media and then subsequently killed, or inactivated, through exposure to heat or chemicals such as formaldehyde 3. Inactivated virus cannot replicate, and therefore cannot cause disease from infection, even in immunocompromised individuals. In contrast, live vaccines are produced from "wild-type" or disease-causing viruses that have been attenuated, or weakened, through various laboratory techniques. Live vaccines maintain their replicative ability.]
Enibomal DB13229
Piperidione DB13224 [Piperidione was cough medicine marketed by Roche under the trade name Sedulon.]
Peracetic acid DB14556 [A liquid that functions as a strong oxidizing agent. It has an acrid odor and is used as a disinfectant.]